Evidence map›Paper›PMID 34198311›Full record

ArticleThe Analyst2021

Isocratic reporter-exclusion immunoassay using restricted-access adsorbents.

Sagar Dhamane, Ujwal Patil, Maxwell Smith, Meena Adhikari, Ahmad Nazem, Jacinta C Conrad, Katerina Kourentzi, Richard C Willson

Abstract read
In one paragraph

Article in The Analyst, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sagar DhamaneDepartment of Biology and Biochemistry, University of Houston, Houston, TX, USA. willson@uh.edu.
Ujwal PatilDepartment of Biology and Biochemistry, University of Houston, Houston, TX, USA. willson@uh.edu.
Maxwell SmithDepartment of Chemical and Biomolecular Engineering, University of Houston, TX, USA.
Meena AdhikariDepartment of Biology and Biochemistry, University of Houston, Houston, TX, USA. willson@uh.edu.
Ahmad NazemDepartment of Biomedical Engineering, University of Houston, Houston, TX, USA.
Jacinta C ConradDepartment of Chemical and Biomolecular Engineering, University of Houston, TX, USA.ORCID http://orcid.org/0000-0001-6084-4772
Katerina KourentziDepartment of Chemical and Biomolecular Engineering, University of Houston, TX, USA.
Richard C WillsonDepartment of Biology and Biochemistry, University of Houston, Houston, TX, USA. willson@uh.edu and Department of Chemical and Biomolecular Engineering, University of Houston, TX, USA and Department of Biomedical Engineering, University of Houston, Houston, TX, USA and Escuela de Medicina y Ciencias de las Salud ITESM, Monterrey, Mexico.ORCID http://orcid.org/0000-0002-0900-6148

Funding

Viral nanoparticles as ultrasensitive reporters in lateral-flow assaysR21AI111120 · NIAID · UNIVERSITY OF HOUSTON · PI WILLSON, RICHARD · 2015 to 2016
$414k
NIAID NIH HHS R21 AI111120
6 · The paper itself

Abstract

We introduce analyte-dependent exclusion of reporter reagents from restricted-access adsorbents as the basis of an isocratic reporter-exclusion immunoassay for viruses, proteins, and other analytes. Capto™ Core 700 and related resins possess a noninteracting size-selective outer layer surrounding a high-capacity nonspecific mixed-mode capture adsorbent core. In the absence of analyte, antibody-enzyme reporter conjugates can enter the adsorbent and be captured, and their signal is lost. In the presence of large or artificially-expanded analytes, reporter reagents bind to analyte species to form complexes large enough to be excluded from the adsorbent core, allowing their signal to be observed. This assay principle is demonstrated using M13 bacteriophage virus and human chorionic gonadotropin as model analytes. The simple isocratic detection approach described here allows a rapid implementation of immunoassay for detection of a wide range of analytes and uses inexpensive, generally-applicable, and stable column materials instead of costly analyte-specific immunoaffinity adsorbents.

Indexed as

Bacteriophage M13Chorionic GonadotropinHumansImmunoassayIndicators and ReagentsChorionic GonadotropinIndicators and Reagents

Identifiers

PMID34198311
PMCPMC9798887

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.